Baxter starts shipments of intravenous products to U.S. from international facilities

Reuters (10/14, Leo) reports, “Baxter International began shipments of intravenous products to the United States from two international facilities last week, it said on Monday, as it works to bring a hurricane-hit plant in North Carolina back online amid a shortage of the essential medical product.” Baxter also received the FDA’s “clearance on Oct. 9 to temporarily import products from five facilities in Canada, China, Ireland, and the U.K., and was working to secure authorization for more sites amid a nationwide shortage following flooding of the plant by Hurricane Helene late last month.” On Monday, the company “said its current priority is deep cleaning the facility and assessing the status of all equipment and production lines.”